Barclays’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Sell |
32,270
-113,801
| -78% | -$106K | ﹤0.01% | 4029 |
|
|
2025
Q1 | $67K | Sell |
146,071
-97,245
| -40% | -$44.6K | ﹤0.01% | 3809 |
|
|
2024
Q4 | $180K | Buy |
243,316
+49,443
| +26% | +$36.6K | ﹤0.01% | 3568 |
|
|
2024
Q3 | $304K | Buy |
193,873
+154,436
| +392% | +$242K | ﹤0.01% | 3278 |
|
|
2024
Q2 | $66K | Sell |
39,437
-25,182
| -39% | -$42.1K | ﹤0.01% | 3565 |
|
|
2024
Q1 | $155K | Sell |
64,619
-62,397
| -49% | -$150K | ﹤0.01% | 3456 |
|
|
2023
Q4 | $195K | Buy |
127,016
+87,827
| +224% | +$135K | ﹤0.01% | 3518 |
|
|
2023
Q3 | $42K | Buy |
39,189
+1,520
| +4% | +$1.63K | ﹤0.01% | 3666 |
|
|
2023
Q2 | $86K | Sell |
37,669
-4,627
| -11% | -$10.6K | ﹤0.01% | 3448 |
|
|
2023
Q1 | $103K | Buy |
42,296
+19,936
| +89% | +$48.5K | ﹤0.01% | 3507 |
|
|
2022
Q4 | $42K | Buy |
22,360
+18,829
| +533% | +$35.4K | ﹤0.01% | 3830 |
|
|
2022
Q3 | $8K | Sell |
3,531
-71,723
| -95% | -$162K | ﹤0.01% | 4265 |
|
|
2022
Q2 | $140K | Sell |
75,254
-7,983
| -10% | -$14.9K | ﹤0.01% | 3312 |
|
|
2022
Q1 | $175K | Sell |
83,237
-1,733
| -2% | -$3.64K | ﹤0.01% | 3392 |
|
|
2021
Q4 | $335K | Buy |
84,970
+57,223
| +206% | +$226K | ﹤0.01% | 2676 |
|
|
2021
Q3 | $134K | Buy |
27,747
+14,497
| +109% | +$70K | ﹤0.01% | 3123 |
|
|
2021
Q2 | $60K | Sell |
13,250
-28,378
| -68% | -$129K | ﹤0.01% | 3327 |
|
|
2021
Q1 | $244K | Buy |
41,628
+28,248
| +211% | +$166K | ﹤0.01% | 3045 |
|
|
2020
Q4 | $46K | Sell |
13,380
-5,779
| -30% | -$19.9K | ﹤0.01% | 3206 |
|
|
2020
Q3 | $27K | Sell |
19,159
-123,870
| -87% | -$175K | ﹤0.01% | 3453 |
|
|
2020
Q2 | $287K | Buy |
143,029
+72,550
| +103% | +$146K | ﹤0.01% | 2628 |
|
|
2020
Q1 | $138K | Buy |
70,479
+12,375
| +21% | +$24.2K | ﹤0.01% | 2692 |
|
|
2019
Q4 | $241K | Buy |
58,104
+33,100
| +132% | +$137K | ﹤0.01% | 3088 |
|
|
2019
Q3 | $75K | Sell |
25,004
-2,050
| -8% | -$6.15K | ﹤0.01% | 3541 |
|
|
2019
Q2 | $170K | Buy |
27,054
+10,944
| +68% | +$68.8K | ﹤0.01% | 3294 |
|
|
2019
Q1 | $89K | Buy |
16,110
+13,503
| +518% | +$74.6K | ﹤0.01% | 3387 |
|
|
2018
Q4 | $18K | Sell |
2,607
-20,042
| -88% | -$138K | ﹤0.01% | 3415 |
|
|
2018
Q3 | $241K | Buy |
22,649
+19,485
| +616% | +$207K | ﹤0.01% | 2981 |
|
|
2018
Q2 | $38K | Sell |
3,164
-15,800
| -83% | -$190K | ﹤0.01% | 3393 |
|
|
2018
Q1 | $163K | Sell |
18,964
-39,281
| -67% | -$338K | ﹤0.01% | 2937 |
|
|
2017
Q4 | $575K | Buy |
58,245
+19,874
| +52% | +$196K | ﹤0.01% | 1981 |
|
|
2017
Q3 | $471K | Buy |
38,371
+8,123
| +27% | +$99.7K | ﹤0.01% | 1953 |
|
|
2017
Q2 | $498K | Buy |
30,248
+17,518
| +138% | +$288K | ﹤0.01% | 1925 |
|
|
2017
Q1 | $183K | Sell |
12,730
-18,084
| -59% | -$260K | ﹤0.01% | 2559 |
|
|
2016
Q4 | $426K | Buy |
30,814
+27,223
| +758% | +$376K | ﹤0.01% | 1903 |
|
|
2016
Q3 | $64K | Sell |
3,591
-59,625
| -94% | -$1.06M | ﹤0.01% | 2629 |
|
|
2016
Q2 | $907K | Buy |
63,216
+60,159
| +1,968% | +$863K | ﹤0.01% | 1484 |
|
|
2016
Q1 | $34K | Sell |
3,057
-32,929
| -92% | -$366K | ﹤0.01% | 2645 |
|
|
2015
Q4 | $468K | Buy |
35,986
+5,885
| +20% | +$76.5K | ﹤0.01% | 1717 |
|
|
2015
Q3 | $300K | Buy |
30,101
+29,304
| +3,677% | +$292K | ﹤0.01% | 1954 |
|
|
2015
Q2 | $6K | Sell |
797
-4,130
| -84% | -$31.1K | ﹤0.01% | 3524 |
|
|
2015
Q1 | $0 | Sell |
4,927
-1,895
| -28% | – | ﹤0.01% | 4117 |
|
|
2014
Q4 | $0 | Sell |
6,822
-2,288
| -25% | – | ﹤0.01% | 4239 |
|
|
2014
Q3 | $63K | Sell |
9,110
-8,717
| -49% | -$60.3K | ﹤0.01% | 2859 |
|
|
2014
Q2 | $125K | Buy |
17,827
+6,890
| +63% | +$48.3K | ﹤0.01% | 2626 |
|
|
2014
Q1 | $77K | Buy |
10,937
+8,615
| +371% | +$60.7K | ﹤0.01% | 2923 |
|
|
2013
Q4 | $16K | Sell |
2,322
-264
| -10% | -$1.82K | ﹤0.01% | 3815 |
|
|
2013
Q3 | $36K | Sell |
2,586
-119
| -4% | -$1.66K | ﹤0.01% | 3311 |
|
|
2013
Q2 | $41K | Buy |
+2,705
| New | +$41K | ﹤0.01% | 3416 |
|